Background:
- We previously showed that HHLA2 is expressed in ~2/3NSCLC and associated with EGFR mutation status (1), and that the majority of PD-L1 neg NSLCC express B7x and HHLA2 (2)
- We sought to explore patterns of PD-L1 and AICs within the TIME and impact on IO outcomes